These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34411990)

  • 1. Unravelling the broader complexity of IL-6 involvement in health and disease.
    Jenkins RH; Hughes STO; Figueras AC; Jones SA
    Cytokine; 2021 Dec; 148():155684. PubMed ID: 34411990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology behind interleukin-6 targeted interventions.
    Liu X; Jones GW; Choy EH; Jones SA
    Curr Opin Rheumatol; 2016 Mar; 28(2):152-60. PubMed ID: 26751841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 as a keystone cytokine in health and disease.
    Hunter CA; Jones SA
    Nat Immunol; 2015 May; 16(5):448-57. PubMed ID: 25898198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6: Biology, signaling and strategies of blockade.
    Schaper F; Rose-John S
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):475-87. PubMed ID: 26189695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interleukin-6 From molecular mechanisms of signal transduction to physiological properties and therapeutic targeting].
    Drutskaya MS; Nosenko MA; Atretkhany KS; Efimov GA; Nedospasov SA
    Mol Biol (Mosk); 2015; 49(6):937-43. PubMed ID: 26710772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.
    Rose-John S
    Int J Biol Sci; 2012; 8(9):1237-47. PubMed ID: 23136552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
    Jones SA; Jenkins BJ
    Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking only the bad side of IL-6 in inflammation and cancer.
    Rose-John S
    Cytokine; 2021 Dec; 148():155690. PubMed ID: 34474215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
    Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
    Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of IL-6 trans-signaling.
    Rose-John S
    Cytokine; 2021 Aug; 144():155577. PubMed ID: 34022535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience of IL-6 blockade in rheumatic diseases - implications on IL-6 biology and disease pathogenesis.
    Davies R; Choy E
    Semin Immunol; 2014 Feb; 26(1):97-104. PubMed ID: 24389239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatile functions for IL-6 in metabolism and cancer.
    Mauer J; Denson JL; Brüning JC
    Trends Immunol; 2015 Feb; 36(2):92-101. PubMed ID: 25616716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation.
    Radtke S; Wüller S; Yang XP; Lippok BE; Mütze B; Mais C; de Leur HS; Bode JG; Gaestel M; Heinrich PC; Behrmann I; Schaper F; Hermanns HM
    J Cell Sci; 2010 Mar; 123(Pt 6):947-59. PubMed ID: 20200229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 Family Cytokines Immunobiology and Structure.
    Wei H; Li B; Sun A; Guo F
    Adv Exp Med Biol; 2019; 1172():79-96. PubMed ID: 31628652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine Levels in the
    Olender A; Bogut A; Magryś A; Tabarkiewicz J
    Pol J Microbiol; 2019 Dec; 68(4):457-464. PubMed ID: 31880890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6: A Masterplayer in the Cytokine Network.
    Uciechowski P; Dempke WCM
    Oncology; 2020; 98(3):131-137. PubMed ID: 31958792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.
    Jordan SC; Choi J; Kim I; Wu G; Toyoda M; Shin B; Vo A
    Transplantation; 2017 Jan; 101(1):32-44. PubMed ID: 27547870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells.
    Russell MA; Cooper AC; Dhayal S; Morgan NG
    Islets; 2013; 5(2):95-105. PubMed ID: 23510983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene of the month: Interleukin 6 (IL-6).
    Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
    J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1ß, and TNF-α, and the TLR4/TLR2/NF-κB/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells.
    Wu J; Niu P; Zhao Y; Cheng Y; Chen W; Lin L; Lu J; Cheng X; Xu Z
    PLoS One; 2019; 14(2):e0212063. PubMed ID: 30807577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.